[What is the actual lesson from the WHI study upon its completion?]

Area of Science:

• Reproductive Endocrinology
• Menopause Management
• Clinical Pharmacology

Background:

• The Women\'s Health Initiative (WHI) study results have been widely misinterpreted, leading to negative perceptions of hormone replacement therapy (HRT).
• This has caused many postmenopausal women to discontinue HRT due to unfounded fears of adverse effects.
• The typical patient seeking HRT is younger and symptomatic, unlike the cohort studied in WHI.

Discussion:

• Re-evaluation of the WHI estrogen-progestin arm data reveals a minimal excess risk of 0.1% per year for breast cancer and cardiovascular events.
• No increased risk was observed in women under 60 years of age.
• Preliminary data from the estrogen-only arm suggests a potential reduction in coronary events and breast cancer risk.

Key Insights:

• The perceived risks of HRT are overestimated due to misinterpretation of the WHI study.
• HRT is generally safe and effective for younger postmenopausal women with symptoms.
• The WHI study population (older women) does not reflect the typical HRT candidate.

Outlook:

• Further research should focus on individualized HRT risk-benefit assessments for diverse patient populations.
• Clinical guidelines should be updated to reflect the nuanced interpretation of HRT safety data.
• Encouraging appropriate HRT use can improve quality of life for symptomatic postmenopausal women.